In fact, while a smaller number of genes was determined from the Haferlach cohorts, a much higher number of genes was observed when stratifying patients from the TARGET-AML cohorts, although no significant association between MYB and MAFB was determined for those patients. This evidence concerns the gene MAFB and acute myeloid leukemia.